PortalPublikationenAdjuvant trastuzumab in HER2-positive breast cancer.

Adjuvant trastuzumab in HER2-positive breast cancer.

Links

  • Dennis Slamon
  • Wolfgang Eiermann
  • Nicholas Robert
  • Tadeusz Pienkowski
  • Miguel Martin
  • Michael Press
  • John Mackey
  • John Glaspy
  • Arlene Chan
  • Marek Pawlicki
  • Tamas Pinter
  • Vicente Valero
  • Mei-Ching Liu
  • Guido Sauter
  • Gunter von Minckwitz
  • Frances Visco
  • Valerie Bee
  • Marc Buyse
  • Belguendouz Bendahmane
  • Isabelle Tabah-Fisch
  • Mary-Ann Lindsay
  • Alessandro Riva
  • John Crown
  • Breast Cancer International Research Group

Beteiligte Einrichtungen

Abstract

Trastuzumab improves survival in the adjuvant treatment of HER-positive breast cancer, although combined therapy with anthracycline-based regimens has been associated with cardiac toxicity. We wanted to evaluate the efficacy and safety of a new nonanthracycline regimen with trastuzumab.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer14
ISSN0028-4793
StatusVeröffentlicht - 2011
pubmed 21991949